Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Montrose2on Jun 11, 2010 1:33pm
427 Views
Post# 17181254

RE: Re: Sales growth

RE: Re: Sales growth
Using percentage #'s to interpret such a limited amount of data can only give a false impression.  Those tactics are often used for penny stocks who by virtue of going from .01 to .03 have shown 200 percent growth.  That usually overlooks the fact that the issue once traded for 2.00 plus.

In my view the only worthwhile information in that article is the comment that "we are in early days" which is very true given only four or five weeks of data AND the fact that there is a constant increment in the weekly # of prescriptions.  That would seem to be a logical extension of more doctors visited, more samples available, where proven effective more prescriptions written.

Once we get some plateauing of the prescription #'s then we can work toward annual projections.

Onward and Upward.
Bullboard Posts